Repeat Spine Stereotactic Body Radiation Therapy After Prior Stereotactic Body Radiation Therapy for Spinal Metastases: Outcomes, Patterns of Failure, and Dosimetric Associations in a Multidisciplinary Spine Oncology Program
Advances in Radiation Oncology · 2026-11 · 11 (11) · 102148
DOI: 10.1016/j.adro.2026.102148 ↗Kurz gefasst
Fachartikel in der Zeitschrift Advances in Radiation Oncology, 2026-11. Verfasst von Ian Messing und 18 weiteren Autor:innen. Beteiligte Einrichtung: Department of Radiation Oncology, University of Pennsylvania, Philadelphia, PA, 19104. Die Arbeit nennt 45 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Purpose
Outcomes after repeat stereotactic body radiation therapy (SBRT2) for spinal metastases progressing after prior SBRT (SBRT1) remain incompletely defined. We evaluated local control (LC), overall survival (OS), pain response, toxicity, and predictors of outcome after salvage SBRT2. Methods and Materials: Patients treated with SBRT2 for in-field failure or adjacent-level progression after SBRT1 between January 2018 and October 2025 were retrospectively reviewed. The primary endpoint was LC. Secondary endpoints included OS, pain response, toxicity, and predictors of outcome. LC was analyzed using cumulative incidence and Fine-Gray regression, and OS was estimated using Kaplan-Meier analysis. Target dose heterogeneity was assessed using the minimum target dose (Dmin 0.03 cc).
Results
Forty-nine patients underwent SBRT2 to 115 vertebral segments. Median OS was 17.6 months, with 6- and 12-month OS rates of 76% and 57%. Disease extent strongly influenced survival. Patients with oligometastatic disease had longer OS than those with extensive disease (31.6 vs 7.4 months; 12-month OS, 88% vs 36%; P < .001). The cumulative incidence of local failure was 15% at 6 months and 25% at 12 months. A higher delivered target dose was associated with improved LC. Patients treated to Dmin ≥28 Gy had lower 12-month local failure than those treated to
Autor:innen und Institutionen
- Department of Radiation Oncology, University of Pennsylvania, Philadelphia, PA, 19104.
- Department of Neurosurgery, University of Pennsylvania, Philadelphia, PA, 19104.
- Department of Radiology, University of Pennsylvania, Philadelphia, PA, 19104.
Zitieren
APA
Messing, I., Ramesh, S., Ramkissoon, A., Park, K., Golubovsky, J., Adelizzi, A., Baron, J., Berger, M., Riina, M. D., Koger, B., Dolney, V., Scheuermann, R., Hassankhani, A., Freeman, C., Schuster, J. M., Shin, J. H., Malhotra, N. R., Peters, G. W., & Butala, A. A. (2026). Repeat Spine Stereotactic Body Radiation Therapy After Prior Stereotactic Body Radiation Therapy for Spinal Metastases: Outcomes, Patterns of Failure, and Dosimetric Associations in a Multidisciplinary Spine Oncology Program. Advances in Radiation Oncology, 11(11), 102148. https://doi.org/10.1016/j.adro.2026.102148
Vancouver
Messing I, Ramesh S, Ramkissoon A, Park K, Golubovsky J, Adelizzi A, et al. Repeat Spine Stereotactic Body Radiation Therapy After Prior Stereotactic Body Radiation Therapy for Spinal Metastases: Outcomes, Patterns of Failure, and Dosimetric Associations in a Multidisciplinary Spine Oncology Program. Advances in Radiation Oncology. 2026;11(11):102148. doi:10.1016/j.adro.2026.102148
BibTeX
@article{Messing2026,
author = {Messing, Ian and Ramesh, Sidharth and Ramkissoon, Avinash and Park, Kristen and Golubovsky, Joshua and Adelizzi, Alyssa and Baron, Jonathan and Berger, Melanie and Riina, Matthew D and Koger, Brandon and Dolney, Valentina and Scheuermann, Ryan and Hassankhani, Alvand and Freeman, Colbey and Schuster, James M and Shin, John H and Malhotra, Neil R and Peters, Gabrielle W and Butala, Anish A},
title = {Repeat Spine Stereotactic Body Radiation Therapy After Prior Stereotactic Body Radiation Therapy for Spinal Metastases: Outcomes, Patterns of Failure, and Dosimetric Associations in a Multidisciplinary Spine Oncology Program},
journal = {Advances in Radiation Oncology},
year = {2026},
volume = {11},
number = {11},
pages = {102148},
doi = {10.1016/j.adro.2026.102148}
}
EUVIMED